top of page

Strategists and Implementers
for growing companies globally
Recent Postings


MedNews: Spectral AI (Nasdaq: MDAI) raises about $5 Million to strengthen its finances for an FDA Pathway
Spectral AI is a predictive AI company focused on medical diagnostics for faster and more accurate treatment decisions in wound decisions in
Nov 19, 20242 min read


MedNews: Nyxoah raises $27 million for its breakthrough treatment alternatives for Obstructive Sleep Apnea through neuromodulation
Nyxoah is reinventing sleep for the billion people that suffer from obstructive sleep apnea (OSA).
Oct 9, 20244 min read


MedNews: Triveni Bio raises $115 million to develop therapeutics addressing immunological and inflammatory disorders
Using a genetics-informed, precision medicine approach, the company seeks to establish proof-of-concept early in drug development
Oct 3, 20242 min read


MedNews: CSA Medical raises $53 million to advance its RejuvenAir System utilizing liquid nitrogen spray cryotherapy for the treatment of chronic bronchitis
This round will fund the company though expected FDA premarket approval and the building of a commercialization strategy
Sep 9, 20243 min read


MedNews: XII MEDICAL closes $45 million financing to advance its neuromodulation therapy for obstructive sleep apnea
It is estimated that 425 million people, globally, have moderate to severe obstructive sleep apnea
Aug 23, 20243 min read


MedNews: EHE Health, the leader in employer-based preventive healthcare is acquired by Consello Capital
EHE's comprehensive, evidence-based preventive care provides 100% of the recommended screenings, resulting in more health conditions being f
Aug 11, 20243 min read


TechNews: Cyclotron technology innovator and isotope manufacturer IONETIX closes financing led by Tees River and Eli Lilly and Company
distribution supply chain includes contract drug manufacturing and "white glove" distribution logistics, allowing global access...
Aug 8, 20243 min read

MedNews: Clinical biopharmaceutical company Sellas Life Sciences, focused on the development of novel therapies for a broad range of cancer indications, raises $21 million
SELLAS is a clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications
Aug 4, 20243 min read

MedNews: AI-enabled biotechnology company ReviR Therapeutics raises $30 million to advance oral genetic medicines for multiple CNS disorders
ReviR Therapeutics is a biopharmaceutical company focused on the development of RNA-targeting small molecule therapies
Jul 27, 20245 min read


MedNews: clinical-stage biotherapeutics company Rani Therapeutics, focused on the oral delivery of biologics and drugs, prices $10 million offering
Our mission is to improve the lives of millions of patients suffering from chronic conditions by replacing painful injections with a pill
Jul 25, 20243 min read


ReShape Lifesciences, a weight loss and metabolic health-solutions company to merge with clinical stage specialty pharmaceutical company Vyome, and acquire assets of metabolic health Biorad Medisys
ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, and Vyome Therapeutics,
Jul 10, 20246 min read

MedNews: Adult stem cell therapeutics developer BrainStorm Cell Therapeutics (Nasdaq: BCLI) raises $4 million
Autologous MSC-NTF cells have received Orphan Drug designation status from the FDA and the European Medicines Agency
Jul 6, 20243 min read


MedNews: Holoclara closes $16 Million financing to advance worm-derived therapies for allergic and autoimmune disease
The company’s discovery engine builds on Dr. Choe’s research uncovering a unique pheromone language shared by roundworms
Jun 30, 20244 min read


MedNews: Ehealth Technologies partners with CancerX and the White House cancer moonshot to boost cancer innovation
Our patented technology with embedded AI collects and clinically organizes patient data, including records, lab results, images...
Jun 18, 20243 min read


MedNews: Avinger (Nasdaq: AVGR) prices share and warrant offering of up to $24 million at $1.66 per share
Avinger is a medical device company that has developed the first image-guided, catheter-based system for patients with vascular disease.
Jun 16, 20244 min read


MedNews: InduPro raises $85 Million to advance next-generation, proximity-based protein therapeutics for the treatment of cancer and autoimmune diseases
The financing will support the advancement of the first expected clinical product candidate targeting cancer tissue
Jun 14, 20245 min read


MedNews: Employee well being technology provider Navigate Wellbeing partners with content solution provider Caravan Wellness to benefit employees
This collaboration focuses on innovative workplace wellness programs, financial well-being education, mental and emotional health...
Jun 10, 20243 min read


MedNews: Immuno-pharma research and development company, AIM ImmunoTech raises $2 million from one investor
The Company’s lead product is a first-in-class investigational drug for cancers, viral diseases and disorders of the immune system
Jun 8, 20243 min read


MedNews: BMI OrganBank announces promising preclinical kidney transplant data for a novel medical device to reduce the wait-list for organ transplants
BMI OrganBank develops novel perfusion systems that can preserve and recondition organs and tissues.
Jun 6, 20243 min read


MedNews: GRIT Biotechnology and Quangang Pharmaceutical partner to jointly develop a globally standardized IL-2 for solid tumor patients receiving T-cell therapy
Grit is a clinical stage cell therapy company leading the tumor infiltrating lymphocytes (TILs) therapy development
Jun 1, 20242 min read
bottom of page